Parallax Volatility Advisers, L.P. Enanta Pharmaceuticals Inc Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $283,046 - $374,181	-5,049 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $270,915 - $438,262	4,501 Added 821.35%	5,049 $378,000
Q1 2021 May 14, 2021	BUY	$41.69 - $54.95 $22,846 - $30,112	548 New	548 $27,000
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $67,885 - $81,287	-835 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $57,681 - $88,226	835 New	835 $80,000
Q1 2018 May 15, 2018	SELL	$57.91 - $92.15 $136,204 - $216,736	-2,352 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $107,368 - $139,638	2,352	2,352 $138,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $198M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.